Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIrish Cont. Regulatory News (ICGC)

Share Price Information for Irish Cont. (ICGC)

Share Price is delayed by 15 minutes
Get Live Data
540.00    0.00 (0.00%)
Bid:
525.00
Ask:
550.00
Spread: 25.00 (4.762%)
Market Cap: £801.54m
ICGC Live PriceLast checked at - London Stock Exchange

Intraday Irish Cont. Share Chart

Offer Update

4 Apr 2007 07:35

Irish Continental Group PLC04 April 2007 4 April 2007 Irish Continental Group plc ("ICG" or the "Company") Update announcement regarding the recommended acquisition of ICG by Aella plc On 8 March 2007 the independent directors of ICG and the board of directors ofAella plc ("Aella") announced the terms of a recommended acquisition for cash ofthe entire issued and to be issued share capital of ICG by Aella for cashconsideration of €18.50 per ICG Unit. Following on from this announcement, on 20March 2007, the Company posted the Scheme Document to ICG shareholders andannounced that the shareholder meetings to approve the acquisition would takeplace on 12 April 2007. Since the announcement of the proposed acquisition by Aella, the IndependentDirectors of ICG (John B McGuckian, Bernard Somers and Peter Crowley) have notedthat there has been significant trading in ICG units at prices in excess of€18.50 per ICG Unit and also that there has been certain press speculation andcommentary regarding potential higher competing offers being announced for theCompany. In light of these factors the Independent Directors would like to highlight thefollowing facts to shareholders in advance of the shareholder meetings on 12April: •there have been no announcements from third parties regarding either a firm intention to make a competing offer or a possible intention to make a competing offer in accordance with Rules 2.5 and 2.4 respectively of the Irish Takeover Rules; •the Independent Directors have not received any approaches from any third parties regarding making a competing offer nor have there been any requests for access to due diligence information in accordance with Rule 20.2 of the Irish Takeover Rules; •the recommended offer from Aella of €18.50 per ICG Unit was the result of intensive negotiations between the Independent Directors and Aella and was materially higher than the offer level at which Aella made its initial approach to the Company; •the offer of €18.50 per ICG Unit represents a premium of: + €18.6 per cent. to the closing ICG Unit price of €15.60 on 7 March 2007, the date immediately prior to the commencement of the offer period; and + €45.0 per cent. to the average ICG Unit price over the six months preceding Aella's approach to the Company of €12.76; •Aella has not disclosed any intention to increase its offer above €18.50 per ICG Unit; and •finally, should the acquisition not be approved by shareholders, in accordance with Rule 35 of the Irish Takeover Rules, except with the consent of the Irish Takeover Panel, Aella and its shareholders may be prevented from making another offer for the Company for a period of 12 months. Shareholders are asked to carefully consider these facts as part of theirdecision whether to vote in favour of or against the acquisition at theshareholder meetings on 12 April 2007. These facts are correct as at the date ofthis announcement. Should it be necessary, a further announcement will be madein due course. The shareholder meetings to approve the acquisition, comprising two courtmeetings and an extraordinary general meeting (the "EGM"), will all take placeat The Berkeley Court Hotel, Lansdowne Road, Dublin 4 on 12 April 2007 with thefirst court meeting commencing at 3.15 pm, the second court meeting commencingat 3.30 pm (or as soon thereafter as the first court meeting has concluded orbeen adjourned), and the EGM commencing at 3.45 pm (or as soon thereafter as thesecond court meeting has concluded or been adjourned). Whether or not shareholders wish to attend the shareholder meetings,shareholders are asked to return the forms of proxy for the court meetings andthe EGM relating to the acquisition which accompanied the Scheme Document toComputershare Investor Services (Ireland) Limited no later than 48 hours priorto the commencement of each meeting. If the forms of proxy for the courtmeetings are not lodged 48 hours prior to the commencement of the meetings theymay be handed to the chairman of the relevant court meeting before the start ofthe relevant court meeting. The completion and return of a form of proxy for anyof the meetings will not prevent ICG shareholders from attending and voting atthe meetings in person if they wish to do so. Enquiries Irish Continental Group plc Telephone +353 1 855 2222 Independent Directors John B McGuckian NCB Corporate Finance Telephone +353 1 611 5611 Liam Booth Jonathan Simmons Shane Lawlor The Independent Directors of Irish Continental Group plc accept responsibilityfor the information contained in this announcement. To the best of theirknowledge and belief (having taken all reasonable care to ensure that such isthe case), the information contained in this announcement for which they takeresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. NCB Corporate Finance Limited, which is authorised in Ireland by the FinancialRegulator under the Investment Intermediaries Act 1995, is acting exclusivelyfor Irish Continental Group plc and no one else in connection with theacquisition and will not be responsible to anyone other than Irish ContinentalGroup plc for providing the protections afforded to clients of NCB CorporateFinance Limited nor for providing advice in relation to the acquisition. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Aug 20257:00 amGNWHalf-year report
25th Aug 20254:47 pmGNWHolding(s) in Company
18th Aug 20257:00 amGNWHolding(s) in Company
1st Jul 20254:30 pmGNWHolding(s) in Company
2nd Jun 20257:00 amGNWTotal voting rights
30th May 20259:30 amGNWBlock listing Interim Review
14th May 20257:00 amGNWTransaction in Own Shares
8th May 20253:38 pmGNWResult of AGM
8th May 20257:00 amGNWTrading Statement
2nd May 20255:54 pmGNWHolding(s) in Company
1st May 20257:00 amGNWTotal voting rights
29th Apr 20257:00 amGNWTransaction in Own Shares
28th Apr 20257:00 amGNWTransaction in Own Shares
7th Apr 20253:00 pmGNWAnnual Financial Report
7th Apr 20253:00 pmGNWNotice of AGM
4th Apr 20257:00 amGNWTransaction in Own Shares
2nd Apr 20254:30 pmGNWHolding(s) in Company
2nd Apr 20257:00 amGNWTransaction in Own Shares
1st Apr 20257:00 amGNWTotal voting rights
27th Mar 20257:00 amGNWTransaction in Own Shares
25th Mar 20257:00 amGNWTransaction in Own Shares
13th Mar 20257:00 amGNWTransaction in Own Shares
5th Mar 20253:24 pmGNWDirector/PDMR Shareholding
5th Mar 20257:00 amGNWTransaction in Own Shares
4th Mar 20255:00 pmGNWDirector/PDMR Shareholding
4th Mar 20255:00 pmGNWDirector/PDMR Shareholding
4th Mar 20255:00 pmGNWDirector/PDMR Shareholding
4th Mar 20255:00 pmGNWDirector/PDMR Shareholding
4th Mar 20255:00 pmGNWDirector/PDMR Shareholding
3rd Mar 20257:00 amGNWTotal voting rights
3rd Mar 20257:00 amGNWPreliminary Statement of Results for the year ended 31 December 2024
31st Jan 20257:00 amGNWHolding(s) in Company
27th Jan 20257:00 amGNWHolding(s) in Company
23rd Dec 20244:01 pmGNWHolding(s) in Company
23rd Dec 20244:00 pmGNWDirector/PDMR Shareholding
26th Nov 20247:00 amGNWTrading Statement
1st Oct 20247:00 amGNWTotal voting rights
1st Oct 20247:00 amGNWBlock listing Interim Review
29th Aug 20247:00 amGNWHalf-year report
1st Aug 20243:22 pmGNWHolding(s) in Company
1st Aug 202412:01 pmGNWTotal voting rights
29th Jul 202410:14 amGNWHolding(s) in Company
25th Jul 20249:28 amGNWHolding(s) in Company
2nd Jul 20244:15 pmGNWHolding(s) in Company
11th Jun 20249:31 amGNWHolding(s) in Company
4th Jun 20247:00 amGNWTotal voting rights
29th May 20244:30 pmGNWDirector/PDMR Shareholding
20th May 20243:14 pmGNWDirector/PDMR Shareholding
20th May 20243:14 pmGNWHolding(s) in Company
20th May 20243:14 pmGNWHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.